What Researchers Should Look For
When sourcing BPC-157 for in-vitro laboratory work in the UK, purity and documentation are the two non-negotiable criteria. The compound should meet a minimum 98% purity threshold as verified by HPLC. Mass spectrometry confirmation is an additional quality indicator worth requesting.
Every batch should come with a lot-specific Certificate of Analysis. A CoA confirms the compound's identity, purity level, and batch number — essential documentation for reproducible research. Generic or non-lot-specific CoAs are a red flag.
Storage and Handling Requirements
BPC-157 is supplied as a white lyophilised powder. For UK laboratory settings, the compound should be stored at -20°C in a desiccated environment, away from light. Suppliers should dispatch it cold to preserve integrity during transit.
Room temperature storage or shipment without temperature control can degrade the compound before it reaches your bench, compromising experimental results.
Regulatory Context in the UK
BPC-157 is not a licensed medicine in the United Kingdom and is not approved by the MHRA for human use. It is sold legally in the UK strictly for in-vitro laboratory research purposes only. Researchers purchasing BPC-157 confirm they are doing so for legitimate research applications and accept full responsibility for compliant handling under applicable law.
Alluvi Labs — UK Research Peptide Supplier
Alluvi Labs supplies BPC-157 for in-vitro laboratory research from the United Kingdom. Each lot is HPLC-verified to 98% purity, accompanied by a batch-specific CoA, and dispatched cold within 48 hours.
For laboratory research use only. Not for human consumption, therapeutic, veterinary, or diagnostic use.